Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v17-FR | Version v15-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2025-04-25 | 2025-04-25 |
| Drug Identification Number | 02267667 | 02267667 |
| Brand name | RABAVERT | RABAVERT |
| Common or Proper name | Inactivated rabies virus (Flury LEP) | Inactivated rabies virus (Flury LEP) |
| Company Name | BAVARIAN NORDIC AS | BAVARIAN NORDIC AS |
| Ingredients | INACTIVATED RABIES VIRUS | INACTIVATED RABIES VIRUS |
| Strength(s) | 2.5UNIT | 2.5UNIT |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | 1 RabAvert vial and 1 Diluent prefilled syringe | 1 RabAvert vial and 1 Diluent prefilled syringe |
| ATC code | J07BG | J07BG |
| ATC description | VIRAL VACCINES | VIRAL VACCINES |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2024-10-17 | 2024-10-17 |
| Actual start date | 2024-10-17 | 2024-10-17 |
| Estimated end date | 2025-05-02 | 2025-05-02 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Doses available to the public market. Impact on the private market only. | Doses available to the public market. Impact on the private market only. |
| Health Canada comments |